These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31288238)

  • 1. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Role of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Irradiated for Glioblastoma Multiforme.
    Zemskova O; Yu NY; Löser A; Leppert J; Rades D
    Cancer Diagn Progn; 2024; 4(4):408-415. PubMed ID: 38962535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001.
    Blumenthal DT; Rankin C; Stelzer KJ; Spence AM; Sloan AE; Moore DF; Padula GD; Schulman SB; Wade ML; Rushing EJ
    Int J Clin Oncol; 2015 Aug; 20(4):650-8. PubMed ID: 25407559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and Treatment Algorithm in Glioblastoma Patients 80 Years and Older.
    Fogg D; Gersey ZC; Pease M; Mallela AN; Andrews E; Plute T; Pearce TM; Njoku-Austin C; Anthony A; Amankulor NM; Zinn P
    World Neurosurg; 2023 Oct; 178():e540-e548. PubMed ID: 37516146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma in the elderly: treatment patterns and survival.
    Pretanvil JA; Salinas IQ; Piccioni DE
    CNS Oncol; 2017 Jan; 6(1):19-28. PubMed ID: 28001088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
    Gately L; Mesía C; Sepúlveda JM; Del Barco S; Pineda E; Gironés R; Fuster J; Dumas M; Gill S; Navarro LM; Herrero A; Dowling A; de Las Peñas R; Vaz MA; Alonso M; Lwin Z; Harrup R; Peralta S; Long A; Perez-Segura P; Ahern E; Garate CO; Wong M; Campbell R; Cuff K; Jennens R; Gallego O; Underhill C; Martinez-Garcia M; Covela M; Cooper A; Brown S; Rosenthal M; Torres J; Collins IM; Gibbs P; Balana C
    J Neurooncol; 2024 Jun; 168(2):299-306. PubMed ID: 38630385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma Recurrence Versus Treatment Effect in a Pathology-Documented Series.
    Himes BT; Arnett AL; Merrell KW; Gates MJ; Bhargav AG; Raghunathan A; Brown DA; Burns TC; Parney IF
    Can J Neurol Sci; 2020 Jul; 47(4):525-530. PubMed ID: 32077389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Five Prognostic Scores in Patients Receiving Chemoradiation for Primary Glioblastoma Multiforme.
    Zemskova O; Yu NY; Löser A; Leppert J; Rades D
    In Vivo; 2024; 38(4):1806-1813. PubMed ID: 38936935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients.
    Parker M; Kazemi F; Ahmed AK; Kuo CC; Nair SK; Rincon-Torroella J; Jackson C; Gallia G; Bettegowda C; Weingart J; Brem H; Mukherjee D
    J Neurooncol; 2024 Jun; 168(2):345-353. PubMed ID: 38662150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White Matter Tract Density Index Prediction Model of Overall Survival in Glioblastoma.
    Salvalaggio A; Pini L; Gaiola M; Velco A; Sansone G; Anglani M; Fekonja L; Chioffi F; Picht T; Thiebaut de Schotten M; Zagonel V; Lombardi G; D'Avella D; Corbetta M
    JAMA Neurol; 2023 Nov; 80(11):1222-1231. PubMed ID: 37747720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model.
    Conrad K; Löber-Handwerker R; Hazaymeh M; Rohde V; Malinova V
    J Neurooncol; 2024 Jul; 168(3):425-433. PubMed ID: 38639854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients.
    Uzum Y; Salman T; Oflazoglu U; Yildiz Y; Varol U; Aysin M; Kucukzeybek Y; Alacacioglu A; Tarhan MO
    Bratisl Lek Listy; 2024 Jul; ():. PubMed ID: 38989745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between giant cell glioblastoma and glioblastoma multiforme in the United States: A retrospective cohort study.
    Bin Abdulrahman AK; Bin Abdulrahman KA; Bukhari YR; Faqihi AM; Ruiz JG
    Brain Behav; 2019 Oct; 9(10):e01402. PubMed ID: 31464386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study.
    Woo PYM; Law THP; Lee KKY; Chow JSW; Li LF; Lau SSN; Chan TKT; Ho JMK; Lee MWY; Chan DTM; Poon WS
    Br J Neurosurg; 2023 Jan; ():1-9. PubMed ID: 36654527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
    Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for geriatric scales in glioblastoma.
    Domenech M; Hernandez A; Balana C
    Aging (Albany NY); 2021 Jul; 13(14):17959-17960. PubMed ID: 34309582
    [No Abstract]   [Full Text] [Related]  

  • 17. Standards of care for treatment of recurrent glioblastoma--are we there yet?
    Weller M; Cloughesy T; Perry JR; Wick W
    Neuro Oncol; 2013 Jan; 15(1):4-27. PubMed ID: 23136223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for preoperative and postoperative seizures in patients with glioblastoma according to the 2021 World Health Organization classification.
    Feyissa AM; Sanchez-Boluarte SS; Moniz-Garcia D; Chaichana KL; Sherman WJ; Freund BE; Tatum WO; Middlebrooks EH; Sirven JI; Quinones-Hinojosa A
    Seizure; 2023 Nov; 112():26-31. PubMed ID: 37729723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals.
    Jarmuzek P; Defort P; Kot M; Wawrzyniak-Gramacka E; Morawin B; Zembron-Lacny A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcomes of glioblastoma: 20-year experience in a single Australian institution.
    Lenffer B; Ruben J; Senthi S; Millar J; Ong WL
    J Med Imaging Radiat Oncol; 2024 Mar; 68(2):208-216. PubMed ID: 37997616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.